TREM-1 Cancer Research Results
TREM-1, triggering receptor expressed on myeloid cells-1: Click to Expand ⟱
| Source: |
| Type: |
TREM1 promotes tumor progression, immunosuppression, and resistance to therapy by activating tumor-infiltrating myeloid cells.
sTREM-1 Serum soluble triggering receptor expressed on myeloid cells-1.
High levels of sTREM-1 were observed in 50% of breast cancer, 33.3% of Small Cell Lung carcinoma (SCLC), 26.7% of colorectal cancer and 13.3% of Non Small Cell Lung Carcinoma (NSCLC) patients.
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
*IP-10/CXCL-10↑, *GM-CSF↑, *TREM-1↓, QoL↑, Ca+2↑, ROS↑, Apoptosis↑, OS↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Cell Death ⓘ
Apoptosis↑, 1,
Migration ⓘ
Ca+2↑, 1,
Functional Outcomes ⓘ
OS↑, 1, QoL↑, 1,
Total Targets: 5
Pathway results for Effect on Normal Cells:
Transcription & Epigenetics ⓘ
TREM-1↓, 1,
Immune & Inflammatory Signaling ⓘ
GM-CSF↑, 1, IP-10/CXCL-10↑, 1,
Total Targets: 3
Scientific Paper Hit Count for: TREM-1, triggering receptor expressed on myeloid cells-1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:536 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page